KEMPER Corp (KMPB): Results of Operations and Financial Condition
KEMPER Corp (KMPB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 kmpr20266302026ex992supple.htm EX-99.2 Document Investor Supplement Second Quarter 2026 Caution Regarding Forward-Looking Statements This Investor Supplement may contain or incorporate by reference information that includes or is based on forward-looking statements with
How this was made
The 30-second read
Why it matters
Traders can use the quarter’s disclosed income statement and capital metrics to update near-term expectations for profitability, investment performance, and balance-sheet strength. The filing shows a large GAAP net loss alongside positive adjusted operating income, implying investors will likely differentiate between core underwriting/operating results and impairment or investment valuation effects.
Market read
Q2 2026 results show GAAP net loss of $466.0 million, including $460.0 million goodwill impairment, while adjusted net operating income is $26.3 million.
What to watch
Book value per share fell materially (to $37.22 at Jun 30, 2026 from $45.05 at Mar 31, 2026), which can dominate sentiment even if core operating metrics stabilize.
Background
The document is an SEC Form 8-K with an EX-99.2 investor supplement for Kemper’s Second Quarter 2026, including GAAP and non-GAAP financial highlights and capital metrics.
Ticker impact
Kemper’s 8-K investor supplement reports Q2 2026 results, including a net loss of $466.0 million and adjusted net operating income of $26.3 million.
Near-term volatility risk is elevated as investors reconcile GAAP loss drivers versus adjusted operating profitability and equity/book value pressure.
The text provides concrete P&L and balance-sheet metrics (net loss, goodwill impairment, investment losses, equity and book value per share) but does not include management guidance or a new event beyond the quarter’s reported figures.
Market effects
Reinforces ongoing insurance-sector sensitivity to claims/reserves and investment mark-to-market, with investors likely to scrutinize impairment and reserve dynamics.
Limited, company-specific disclosure for a US insurer.
Low, no cross-border transaction or macro policy action disclosed.
Counterpoint
Investors may focus on adjusted net operating income staying positive ($26.3 million in Q2) and treat GAAP loss as largely non-recurring impairment and investment valuation noise.
Key entities
- companyKemper Corporation
US property and casualty insurer filing an 8-K investor supplement for Q2 2026 results (KMPB).
- regulatory_filingSEC Form 8-K
Primary disclosure vehicle for the quarter’s results and supplemental financial tables.
